JG
COLL icon

Joel Greenblatt’s Collegium Pharmaceutical COLL Stock Holding History

Joel Greenblatt’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.77M Buy
76,441
+20,827
+37% +$712K 0.01% 1076
2026
Q1 		$1.84M Buy
55,614
+45,210
+435% +$1.91M 0.01% 1133
2025
Q4 		$482K Buy
10,404
+2,219
+27% +$92.8K ﹤0.01% 1451
2025
Q3 		$286K Buy
+8,185
New +$285K ﹤0.01% 1524
2025
Q1 		– Sell
-28,074
Closed -$804K – 1569
2024
Q4 		$804K Sell
28,074
-24,032
-46% -$795K 0.01% 980
2024
Q3 		$2.01M Sell
52,106
-9,311
-15% -$332K 0.02% 723
2024
Q2 		$1.98M Buy
61,417
+8,995
+17% +$312K 0.03% 685
2024
Q1 		$2.04M Buy
52,422
+7,560
+17% +$264K 0.03% 644
2023
Q4 		$1.38M Buy
44,862
+1,899
+4% +$47.6K 0.03% 702
2023
Q3 		$960K Buy
42,963
+10,489
+32% +$239K 0.02% 794
2023
Q2 		$698K Buy
32,474
+18,992
+141% +$431K 0.02% 873
2023
Q1 		$323K Buy
+13,482
New +$358K 0.01% 1107
2021
Q3 		– Sell
-11,348
Closed -$268K – 1043
2021
Q2 		$268K Buy
+11,348
New +$262K 0.01% 876

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Joel Greenblatt's COLL Position: Q2 2026 in Review

Joel Greenblatt increased its Collegium Pharmaceutical (COLL) stake by 37% in Q2 2026, buying an estimated $712K and bringing the position to 76,441 shares worth $2.77M. The position accounts for 0.01% of the portfolio, ranked #1076.

Joel Greenblatt first reported a position in COLL in Q2 2021 and has held it in 13 quarters since. 277 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Joel Greenblatt held 76,441 shares of Collegium Pharmaceutical worth $2.77M as of Q2 2026.
  • Joel Greenblatt bought 20,827 Collegium Pharmaceutical shares in Q2 2026, an estimated $712K.
  • Collegium Pharmaceutical made up 0.01% of Joel Greenblatt's portfolio in Q2 2026, its #1076 holding.
  • Joel Greenblatt first reported a position in Collegium Pharmaceutical in Q2 2021 and has held it in 13 quarters since.
  • 277 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.